Pharmafile Logo
Pharmafocus logo
Advanced Search
Photo by Psiĥedelisto

Democratic Senators urge judge to reject Purdue Pharma’s proposal to pay CEO a bonus

September 22, 2020
Manufacturing and Production OxyContin, Purdue, Purdue Pharma

Democratic US Senators are urging Judge Robert D. Drain to reject Purdue Pharma’s proposal to pay CEO and President Craig …

News
shutterstock_38078521

New Lenvima/Keytruda combo data in a range of cancers presented at ESMO 2020

September 21, 2020
Research and Development, Sales and Marketing Cancer, ESMO2020, Eisai, Lenvima, MSD, keytruda

New data from two studies investigating the combination of Eisai’s multiple receptor tyrosine kinase inhibitor Lenvima (lenvatinib) and MSD’s blockbuster …

News
800px-astrazeneca_hq_in_cambridge_uk

AstraZeneca’s Lynparza recommended by the EMA for HRD-positive advanced ovarian cancer

September 21, 2020
Sales and Marketing AstraZeneca

AstraZeneca and MSD’s Lynparza (olaparib) has been recommended for marketing authorisation across the European Union for the first-line maintenance treatment …

News
800px-temazepam_10mg_tablets-1

Acella Pharmaceuticals voluntarily recalls thyroid drugs over lack of potency

September 21, 2020
Sales and Marketing thyroid, thyroid drugs

Acella Pharmaceuticals is recalling two types of its thyroid medication as the drugs may be too weak to properly treat …

News
shutterstock_159488225

Piqray and Faslodex combo extends survival in HR+/HER2-, PIK3CA+ advanced breast cancer at ESMO 2020

September 21, 2020
Research and Development, Sales and Marketing Cancer, ESMO 2020, Novartis, pharma

New data has been unveiled for the combination of Novartis’ Piqray (alpelisib) with AstraZeneca’s Faslodex (fulvestrant) in the treatment of …

News
800px-united_airlines_aircraft_taking_off_at_schiphol_airport

CDC says nearly 11,000 Americans have been exposed to COVID-19 on flights

September 21, 2020
Sales and Marketing COVID-19, air travel, coronavirus

The Centers for Disease Control and Prevention has identified nearly 11,000 people who were potentially exposed to coronavirus while flying.  …

News
libtayo

Promising Phase 2 data for Sanofi and Regeneron’s PD-1 inhibitor Libtayo in locally advanced basal cell carcinoma

September 18, 2020
Medical Communications, Research and Development Cancer, ESMO 2020, Libtayo, Regeneron, Sanofi, pharma

Promising Phase 2 data has been released at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 for Sanofi …

News
800px-lt

Roche says its rheumatoid arthritis drug reduces the need for ventilators in coronavirus patients

September 18, 2020
Medical Communications COVID-19, Roche

Roche says that its Actermra/Roactemra drugs reduce the likelihood that coronavirus patients with virus-related pneumonia will need to be put …

News
256px-mikhail_murashko_2020-01-29

One in seven Russian COVID-19 vaccine recipients display side-effects, says Health Minister

September 18, 2020
Medical Communications, Research and Development COVID-19, Russia, Sputnik V, Vaccine

Around one in seven patients who have received Russia’s vaccine against COVID-19 have displayed side-effects in clinical studies, according to …

News
800px-jnjioffice

New York files $2 billion lawsuit against J&J for downplaying risks of opioids in its marketing

September 18, 2020
Medical Communications new york state, opioid crisis

New York State is suing Johnson & Johnson in a lawsuit seeking $2 billion in damages for the company’s role …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

September 18, 2020
Medical Communications

The top ten news stories this week centre around coronavirus vaccines, with Russia signing a deal with an Indian pharma …

News
novartis_outside_1

Novartis’ Tafinlar/Mekinist combo improves five-year relapse-free survival in new Phase 3 data

September 17, 2020
Research and Development Novartis, Tafinlar, mekinist, melanoma

Novartis has unveiled promising new Phase 3 data for its combination of Tafinlar (dabrafenib) with Mekinist (trametinib) in the treatment …

News

Opdivo scores NICE recommendation in two non-small cell lung cancer indications

September 17, 2020
Sales and Marketing NICE, lung cancer, opdivo

NICE has announced its recommendation of Bristol-Myers Squibb’s blockbuster immunotherapy drug Opdivo (nivolumab) for the treatment of two non-small cell …

News
800px-vaccine_image_1

Oxford University says participant illness that halted its COVID-19 trial may not be linked to the vaccine

September 17, 2020
Research and Development coronavirus vaccines, vaccines

The illness of one of the participants in the Oxford-AstraZeneca COVID-19 vaccine trial may not have been caused by the …

News
donald_trump_29496131773

US sets out plans to distribute free coronavirus vaccines

September 17, 2020
Research and Development

The Trump administration has laid out its strategy to distribute COVID-19 vaccines for free across the US.  The Department of …

News
800px-kodak_colorplus_200_135_film_cartridge_and_box

Independent review finds no evidence of insider trading from Kodak executives before US Government pharma deal

September 17, 2020
Business Services

Kodak has been cleared of insider trading by an independent review after one of its top executives bought shares before …

News
alex_azar_-_pete_marovich-getty_images

HHS Secretary Alex Azar accused of overruling FDA on COVID-19 test quality reviews

September 16, 2020
Research and Development COVID-19, FDA, US, USA

Allegations have emerged accusing US Health and Human Services Secretary Alex Azar of overruling the FDA over the review of …

News
gettyimages-1206570416

India signs deal for 100m doses of Russia’s Sputnik V COVID-19 vaccine

September 16, 2020
Manufacturing and Production, Research and Development COVID-19, India, Russia, Vaccine

Russia has signed a deal with an Indian pharma firm to test and deliver 100 million doses of its controversial …

News
800px-pfizer_finland_hq_february_13_2009

Pfizer’s coronavirus vaccine shows moderate side-effects in clinical study

September 16, 2020
Research and Development COVID-19, Pfizer, Pfizer vaccine, coronavirus vaccine

Pfizer has said that participants in a late-stage trial for its COVID-19 vaccine candidate have shown mild to moderate side …

News
steve_bannon_32289717844

Study that alleges COVID-19 was made in a Chinese lab originated from non-profits linked to ex-Trump advisor Steve Bannon

September 16, 2020
Research and Development China, Donald Trump, Steve Bannon, Wuhan, coronavirus

A new study that alleges COVID-19 was created in a Chinese lab was published by two non-profits that are linked …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025